Ji Chengdong, Zhu Jing, Hou Xiaochen, Zhou Chen, Zhao Jiumei, Zheng Xiang, Tang Yu
Pathology Department, The Ninth People's Hospital of Suzhou, Suzhou, China.
Yunan Key Laboratory of Breast Cancer Precision Medicine, School of Biomedical Engineering, Kunming Medical University, Kunming, China.
J Cell Mol Med. 2025 Jul;29(13):e70675. doi: 10.1111/jcmm.70675.
Polypyrimidine tract binding protein 1 (PTBP1) belongs to the heterogeneous nuclear ribonucleoprotein (hnRNP) family and is a widely studied RNA-binding protein involved in regulating mRNA splicing, stability, localization, and translation. In addition, PTBP1 can participate in various non-coding RNA action processes and affect tumorigenesis and progression. In tumour therapy, PTBP1 may act as a key factor influencing targeted drug targets. Therefore, in this paper, we reviewed the structure and function of PTBP1, its role in various tumours, and key mechanisms of action. Moreover, we discuss the difficulties and challenges faced in PTBP1 research and the clinical translational potential of PTBP1 research and summarise the future research direction of PTBP1 to provide new ideas for basic research and new directions for precision treatment of tumours in the clinic.
多聚嘧啶束结合蛋白1(PTBP1)属于不均一核核糖核蛋白(hnRNP)家族,是一种经过广泛研究的RNA结合蛋白,参与调节mRNA剪接、稳定性、定位和翻译。此外,PTBP1可参与各种非编码RNA作用过程,并影响肿瘤发生和进展。在肿瘤治疗中,PTBP1可能是影响靶向药物靶点的关键因素。因此,本文综述了PTBP1的结构与功能、其在各种肿瘤中的作用及关键作用机制。此外,我们讨论了PTBP1研究面临的困难与挑战以及PTBP1研究的临床转化潜力,并总结了PTBP1未来的研究方向,以期为基础研究提供新思路,为临床肿瘤精准治疗提供新方向。